Results 221 to 230 of about 36,469,020 (258)

Anomaly Detection for Automated Data Quality Monitoring in the CMS Detector. [PDF]

EPJ Res Infrastruct
Brinkerhoff A, Sutantawibul C, Suarez I, White R, Daumann C, Guiang J, Freer C, May S, Marsh B, Acosta D, Aubuchon A, Barberis E, Bundock A, Campagnari C, Collins E, Epps P, Erdmann J, Flaecher H, Huang J, Nguyen V, Nie R, Paramesvaran S, Rotter J, Salyer K, Sawant S, Sheokand T, Wood D, the CMS Muon Detector Collaboration.   +27 more
europepmc   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba, Mark Shacker, Timothy P. Fleming, Michael A. Smith, Ross M. Bremner, Narendra V. Sankpal   +5 more
wiley   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

A Practical Approach to Assessing the Completeness of Electronic Health Records for Medical Research: Data Quality Study. [PDF]

JMIR Med Inform
Lim M, An D, Son N, Sunwoo W, Lee S.
europepmc   +1 more source

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

Molecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir, Elena Haro‐Martínez, Sandra Blasco‐Benito, Chiara Cannatà, José Ángel Palomeque, Anna López‐Plana, Maria Sanz‐Flores, Marc Sabartés, Cristina Fornaguera, Toni Celià‐Terrassa   +9 more
wiley   +1 more source

Assessing data quality of inflammatory bowel disease patients in the <i>All of Us</i> research program. [PDF]

JAMIA Open
Spotnitz M, Faye AS, Giannini J, Litwin TR, Ostchega Y, Berman L.   +5 more
europepmc   +1 more source

Optimization of seminal extracellular vesicle isolation protocols for cancer biomarker analysis using proteomic profiling

Molecular Oncology, EarlyView.
This paper shows that size‐exclusion chromatography and sequential centrifugation applied to seminal plasma enrich for different populations of extracellular vesicles. This may significantly affect the detection and analysis of extracellular vesicle‐associated cancer biomarkers.
Elen Telumyan, Beatriz Martín‐Gracia, Eva Bassols‐Citores, Krizia Sagini, Maria K. Andersen, Tuula A. Nyman, May‐Britt Tessem, Morten B. Rye, Alicia Llorente   +8 more
wiley   +1 more source

Strengthening District- and Regional-Level Supportive Supervision for Facility HMIS Data Quality and Data Use in Somalia: A Healthcare Leadership Commentary. [PDF]

J Healthc Leadersh
Osman NH, Mohamed DO, Hussein AM, Sheikh Ali LA, Mohamed FA, Omar MH, Roble AM, Abdi AM, Omar AA, Adam AA.   +9 more
europepmc   +1 more source